Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Quest Diagnostics Breaks Ground on Clifton Laboratory
Quest Diagnostics broke ground in March of 2019 on a 250,000-sf laboratory in Clifton, N.J. The medical testing facility will be Quest's largest development and will accommodate over 1,100 employees. Supporting increased capacity, the center will provide comprehensive diagnostic services with reduced processing times. Occupancy is expected in 2021. The lab is located on 12 acres in the ON3 campus which offers integrated research, office, and residential facilities in a vibrant environment offering myriad lifestyle amenities.
Amicus Therapeutics Creates Global Research and Gene Therapy Center of Excellence
Amicus Therapeutics is creating the Global Research and Gene Therapy Center of Excellence in Philadelphia. The 75,000-sf facility will provide collaborative laboratories and offices for the discovery and development of treatments for rare metabolic diseases. Accommodating up to 200 employees, the center will serve as the headquarters for the global Amicus science organization and the gene therapy division’s leadership team. Occupancy is expected in the second half of 2019.
Akouos Leases Biotech Headquarters in Boston
Akouos, a genetic medicine company, has leased 37,500 sf in Boston for its research headquarters. The facility is located in a two-story, 150,000-sf building at 645 Summer Street and will support the discovery and commercialization of therapies for hearing disorders. The project was developed by Pappas Enterprises and renovated by Tocci Building Corporation. The sustainably designed structure has attained LEED Silver certification.
Lockheed Martin Opens Research & Development II Facility
Lockheed Martin opened the $50 million Research & Development II facility in Orlando in February of 2019. The six-story, 255,000-sf building offers collaborative offices and laboratories to support engineering, program management, and business operations for the company's Missiles and Fire Control division as well as the Rotary and Mission Systems division. The duration of construction was one year.
Autolus Therapeutics Builds Rockville R&D Headquarters
Autolus Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for the construction and development of a build-to-suit facility in Rockville, Md. Located in the Shady Grove Life Sciences Center, the 85,000-sf project will accommodate the company's U.S. headquarters and a commercial-scale manufacturing center for cell therapies. Occupancy is expected in 2021.